News

Filter

Current filters:

ResearchBiotechnology

1 to 9 of 1279 results

Positive Ph III results for Portola’s Xarelto antidote andexanet alfa

02-03-2015

USA-based Portola Pharmaceuticals saw its shares jump 7.2% to $40.83 after it announced positive results…

andexanet alfaBayerBiotechnologyCardio-vascularPortola PharmaceuticalsRegulationResearchUSA

Amgen's Kyprolis doubles progression-free survival in head-to-head against Velcade

Amgen's Kyprolis doubles progression-free survival in head-to-head against Velcade

02-03-2015

USA-based biotech firm Amgen and its subsidiary Onyx Pharmaceuticals have announced the interim results…

AmgenBiotechnologyKyprolisOncologyResearchUSAVelcade

National Institute of Allergy and Infectious Diseases launches ZMapp Ebola trial with Liberia

National Institute of Allergy and Infectious Diseases launches ZMapp Ebola trial with Liberia

02-03-2015

The USA’s National Institute of Allergy and Infectious Diseases has launched a clinical trial with…

Anti-viralsBiotechnologyLiberiaMapp BiopharmaceuticalResearchZMapp

Positive Ph III results from Biogen Idec and SOBI’s Alprolix in pediatric study

Positive Ph III results from Biogen Idec and SOBI’s Alprolix in pediatric study

28-02-2015

US biotech major Biogen Idec and Nordic drugmaker Swedish Orphan Biovitrum have announced positive top-line…

AlprolixBiogen IdecBiotechnologyEuropeHematologyRegulationResearchSobiSwedish Orphan Biovitrum

Merck enters into collaboration with NGM to develop biologics

Merck enters into collaboration with NGM to develop biologics

24-02-2015

Pharma giant Merck & Co has entered into a collaboration with privately-held biotech company NGM Biopharmaceuticals…

BiotechnologyMerck & CoNGM BiopharmaceuticalsResearchUSA

Health care is up for a revolution with the rise of personal genomic tests; report

24-02-2015

As the era of personalized medicine dawns on health care, the need to understand an individual’s genetic…

BiotechnologyGlobalRegulationResearch

Foundation Medicine and H3 Biomedicine announce oncology collaboration

Foundation Medicine and H3 Biomedicine announce oncology collaboration

23-02-2015

USA-based Foundation Medicine and privately-held US biopharma company H3 Biomedicine have announced a…

BiotechnologyFoundation MedicineH3 BiomedicineOncologyResearchUSA

Cyclenium signs drug discovery and collaboration agreement with Fundación MEDINA

Cyclenium signs drug discovery and collaboration agreement with Fundación MEDINA

23-02-2015

Emerging pharma company Cyclenium, focused on proprietary macrocyclic chemistry, has signed a drug discovery…

Antibiotics and Infectious diseasesBiotechnologyCycleniumFundacion MEDINAResearchSpain

1 to 9 of 1279 results

COMPANY SPOTLIGHT

Menarini

Back to top